Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Bioceres Crop Solutions Corp (NASDAQ: BIOX) was $1.19 for the day, down -5.56% from the previous closing price of $1.26. In other words, the price has decreased by -$5.56 from its previous closing price. On the day, 0.75 million shares were traded. BIOX stock price reached its highest trading level at $1.275 during the session, while it also had its lowest trading level at $1.17.
Ratios:
Our analysis of BIOX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.08. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 10, 2025, Canaccord Genuity Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOX now has a Market Capitalization of 75539792 and an Enterprise Value of 347043616. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 0.29. Its current Enterprise Value per Revenue stands at 1.091 whereas that against EBITDA is 29.39.
Stock Price History:
The Beta on a monthly basis for BIOX is 0.50, which has changed by -0.82 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, BIOX has reached a high of $7.44, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -23.31%, while the 200-Day Moving Average is calculated to be -60.39%.
Shares Statistics:
BIOX traded an average of 771.51K shares per day over the past three months and 444120 shares per day over the past ten days. A total of 61.31M shares are outstanding, with a floating share count of 45.44M. Insiders hold about 28.14% of the company’s shares, while institutions hold 39.70% stake in the company. Shares short for BIOX as of 1767139200 were 1019948 with a Short Ratio of 1.32, compared to 1764288000 on 1097879. Therefore, it implies a Short% of Shares Outstanding of 1019948 and a Short% of Float of 2.75.
Earnings Estimates
The dynamic stock of Bioceres Crop Solutions Corp (BIOX) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.12. Analysts are recommending an EPS of between -$0.16 and -$0.42 for the fiscal current year, implying an average EPS of -$0.29.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 2 analysts. It ranges from a high estimate of $113.1M to a low estimate of $96M. As of. The current estimate, Bioceres Crop Solutions Corp’s year-ago sales were $106.8MFor the next quarter, 2 analysts are estimating revenue of $59M. There is a high estimate of $63.5M for the next quarter, whereas the lowest estimate is $54.5M.
A total of 2 analysts have provided revenue estimates for BIOX’s current fiscal year. The highest revenue estimate was $334.4M, while the lowest revenue estimate was $307.1M, resulting in an average revenue estimate of $320.75M. In the same quarter a year ago, actual revenue was $333.3M
